List of diseases covered by
Fatty Acid Oxidation Disorder NGS panel
| Gene | Condition |
| ACAD9 | Mitochondrial complex I deficiency due to ACAD9 deficiency |
| ACADM | Acyl-CoA dehydrogenase, medium chain, deficiency of |
| ACADS | Acyl-CoA dehydrogenase, short-chain, deficiency of |
| ACADVL | VLCAD deficiency |
| CPT1A | CPT deficiency, hepatic, type IA |
| CPT2 | CPT II deficiency, infantile; CPT II deficiency, lethal neonatal; CPT II deficiency, myopathic, stress-induced |
| ETFA | Glutaric acidemia IIA |
| ETFB | Glutaric acidemia IIB |
| ETFDH | Glutaric acidemia IIC |
| GLUD1 | Hyperinsulinism-hyperammonemia syndrome |
| HADH | 3-hydroxyacyl-CoA dehydrogenase deficiency |
| HADHA | Fatty liver, acute, of pregnancy; Trifunctional protein deficiency |
| HADHB | Trifunctional protein deficiency |
| HMGCL | HMG-CoA lyase deficiency |
| HMGCS2 | HMG-CoA synthase-2 deficiency |
| HSD17B10 | HSD10 mitochondrial disease |
| LPIN1 | Myoglobinuria, acute recurrent, autosomal recessive |
| PPARG | Carotid intimal medial thickness 1; Lipodystrophy, familial partial, type 3; Obesity, severe |
| SLC22A5 | Carnitine deficiency, systemic primary |
| SLC25A20 | Carnitine-acylcarnitine translocase deficiency |
| TAZ | Barth syndrome |